Experimental evaluation of a nNew antithrombogenic stent using ion beam surface modification

Yoichi Sugita, Yoshiaki Suzuki, Kenji Someya, Akira Ogawa, Hiroshi Furuhata, Shinichiro Miyoshi, Tadashi Motomura, Hiroshi Miyamoto, Stephen Igo, Yukihiko Nosé

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A new antithrombogenic stent using ion beam surface modification nanotechnology was evaluated. The ion stent is being developed to inhibit acute and chronic stent-related thrombosis. Thirty self-expanding mesh stents were fabricated from Ti-Ni metal wires with a dimension of 4 mm (diameter) × 25 mm (length) × 0.15 mm (thickness). Twenty stents were coated with type I collagen and irradiated with a He+ ion beam at an energy of 150 keV with fluences of 1 × 1014 ions/cm2 (ion stent group). Ten stents had no treatment (non-ion stent group). The self-expanding stents were implanted into the right and left peripheral femoral arteries of 15 beagle dogs (vessel diameter approximately 3 mm) via a 6Fr catheter under fluoroscopic guidance. Heparin (100 units/kg) was administered intravenously before implantation. Following stent implantation, no antiplatelet or anticoagulant drugs were administered. The 1-month patency rate for the non-ion stent group was 10% (1/10), and for the ion stent group it was 80% (16/20) with no anticoagulant or antiplatelet drugs given after stent implantation (P = 0.0004 by Fisher's exact test). Ten stents remain patent after 2 years in vivo with no anticoagulant or antiplatelet drugs. These results indicate that He + ion-implanted collagen-coated Ti-Ni self-expanding stents have excellent antithrombogenicity and biocompatibility. This ion stent is promising for coronary and cerebral stent applications.

Original languageEnglish
Pages (from-to)456-463
Number of pages8
JournalArtificial Organs
Volume33
Issue number6
DOIs
Publication statusPublished - Jun 2009
Externally publishedYes

Fingerprint

Stents
Ion beams
Surface treatment
Ions
Platelet Aggregation Inhibitors
Anticoagulants
Collagen
Nanotechnology
Catheters
Femoral Artery
Collagen Type I

Keywords

  • Cerebral stent
  • Collagen
  • Coronary stent
  • Ion beam surface modification
  • Neointima

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Bioengineering
  • Medicine (miscellaneous)

Cite this

Sugita, Y., Suzuki, Y., Someya, K., Ogawa, A., Furuhata, H., Miyoshi, S., ... Nosé, Y. (2009). Experimental evaluation of a nNew antithrombogenic stent using ion beam surface modification. Artificial Organs, 33(6), 456-463. https://doi.org/10.1111/j.1525-1594.2009.00747.x

Experimental evaluation of a nNew antithrombogenic stent using ion beam surface modification. / Sugita, Yoichi; Suzuki, Yoshiaki; Someya, Kenji; Ogawa, Akira; Furuhata, Hiroshi; Miyoshi, Shinichiro; Motomura, Tadashi; Miyamoto, Hiroshi; Igo, Stephen; Nosé, Yukihiko.

In: Artificial Organs, Vol. 33, No. 6, 06.2009, p. 456-463.

Research output: Contribution to journalArticle

Sugita, Y, Suzuki, Y, Someya, K, Ogawa, A, Furuhata, H, Miyoshi, S, Motomura, T, Miyamoto, H, Igo, S & Nosé, Y 2009, 'Experimental evaluation of a nNew antithrombogenic stent using ion beam surface modification', Artificial Organs, vol. 33, no. 6, pp. 456-463. https://doi.org/10.1111/j.1525-1594.2009.00747.x
Sugita, Yoichi ; Suzuki, Yoshiaki ; Someya, Kenji ; Ogawa, Akira ; Furuhata, Hiroshi ; Miyoshi, Shinichiro ; Motomura, Tadashi ; Miyamoto, Hiroshi ; Igo, Stephen ; Nosé, Yukihiko. / Experimental evaluation of a nNew antithrombogenic stent using ion beam surface modification. In: Artificial Organs. 2009 ; Vol. 33, No. 6. pp. 456-463.
@article{84f970811ac64a499b0fac0e81bedca6,
title = "Experimental evaluation of a nNew antithrombogenic stent using ion beam surface modification",
abstract = "A new antithrombogenic stent using ion beam surface modification nanotechnology was evaluated. The ion stent is being developed to inhibit acute and chronic stent-related thrombosis. Thirty self-expanding mesh stents were fabricated from Ti-Ni metal wires with a dimension of 4 mm (diameter) × 25 mm (length) × 0.15 mm (thickness). Twenty stents were coated with type I collagen and irradiated with a He+ ion beam at an energy of 150 keV with fluences of 1 × 1014 ions/cm2 (ion stent group). Ten stents had no treatment (non-ion stent group). The self-expanding stents were implanted into the right and left peripheral femoral arteries of 15 beagle dogs (vessel diameter approximately 3 mm) via a 6Fr catheter under fluoroscopic guidance. Heparin (100 units/kg) was administered intravenously before implantation. Following stent implantation, no antiplatelet or anticoagulant drugs were administered. The 1-month patency rate for the non-ion stent group was 10{\%} (1/10), and for the ion stent group it was 80{\%} (16/20) with no anticoagulant or antiplatelet drugs given after stent implantation (P = 0.0004 by Fisher's exact test). Ten stents remain patent after 2 years in vivo with no anticoagulant or antiplatelet drugs. These results indicate that He + ion-implanted collagen-coated Ti-Ni self-expanding stents have excellent antithrombogenicity and biocompatibility. This ion stent is promising for coronary and cerebral stent applications.",
keywords = "Cerebral stent, Collagen, Coronary stent, Ion beam surface modification, Neointima",
author = "Yoichi Sugita and Yoshiaki Suzuki and Kenji Someya and Akira Ogawa and Hiroshi Furuhata and Shinichiro Miyoshi and Tadashi Motomura and Hiroshi Miyamoto and Stephen Igo and Yukihiko Nos{\'e}",
year = "2009",
month = "6",
doi = "10.1111/j.1525-1594.2009.00747.x",
language = "English",
volume = "33",
pages = "456--463",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Experimental evaluation of a nNew antithrombogenic stent using ion beam surface modification

AU - Sugita, Yoichi

AU - Suzuki, Yoshiaki

AU - Someya, Kenji

AU - Ogawa, Akira

AU - Furuhata, Hiroshi

AU - Miyoshi, Shinichiro

AU - Motomura, Tadashi

AU - Miyamoto, Hiroshi

AU - Igo, Stephen

AU - Nosé, Yukihiko

PY - 2009/6

Y1 - 2009/6

N2 - A new antithrombogenic stent using ion beam surface modification nanotechnology was evaluated. The ion stent is being developed to inhibit acute and chronic stent-related thrombosis. Thirty self-expanding mesh stents were fabricated from Ti-Ni metal wires with a dimension of 4 mm (diameter) × 25 mm (length) × 0.15 mm (thickness). Twenty stents were coated with type I collagen and irradiated with a He+ ion beam at an energy of 150 keV with fluences of 1 × 1014 ions/cm2 (ion stent group). Ten stents had no treatment (non-ion stent group). The self-expanding stents were implanted into the right and left peripheral femoral arteries of 15 beagle dogs (vessel diameter approximately 3 mm) via a 6Fr catheter under fluoroscopic guidance. Heparin (100 units/kg) was administered intravenously before implantation. Following stent implantation, no antiplatelet or anticoagulant drugs were administered. The 1-month patency rate for the non-ion stent group was 10% (1/10), and for the ion stent group it was 80% (16/20) with no anticoagulant or antiplatelet drugs given after stent implantation (P = 0.0004 by Fisher's exact test). Ten stents remain patent after 2 years in vivo with no anticoagulant or antiplatelet drugs. These results indicate that He + ion-implanted collagen-coated Ti-Ni self-expanding stents have excellent antithrombogenicity and biocompatibility. This ion stent is promising for coronary and cerebral stent applications.

AB - A new antithrombogenic stent using ion beam surface modification nanotechnology was evaluated. The ion stent is being developed to inhibit acute and chronic stent-related thrombosis. Thirty self-expanding mesh stents were fabricated from Ti-Ni metal wires with a dimension of 4 mm (diameter) × 25 mm (length) × 0.15 mm (thickness). Twenty stents were coated with type I collagen and irradiated with a He+ ion beam at an energy of 150 keV with fluences of 1 × 1014 ions/cm2 (ion stent group). Ten stents had no treatment (non-ion stent group). The self-expanding stents were implanted into the right and left peripheral femoral arteries of 15 beagle dogs (vessel diameter approximately 3 mm) via a 6Fr catheter under fluoroscopic guidance. Heparin (100 units/kg) was administered intravenously before implantation. Following stent implantation, no antiplatelet or anticoagulant drugs were administered. The 1-month patency rate for the non-ion stent group was 10% (1/10), and for the ion stent group it was 80% (16/20) with no anticoagulant or antiplatelet drugs given after stent implantation (P = 0.0004 by Fisher's exact test). Ten stents remain patent after 2 years in vivo with no anticoagulant or antiplatelet drugs. These results indicate that He + ion-implanted collagen-coated Ti-Ni self-expanding stents have excellent antithrombogenicity and biocompatibility. This ion stent is promising for coronary and cerebral stent applications.

KW - Cerebral stent

KW - Collagen

KW - Coronary stent

KW - Ion beam surface modification

KW - Neointima

UR - http://www.scopus.com/inward/record.url?scp=66449121405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66449121405&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1594.2009.00747.x

DO - 10.1111/j.1525-1594.2009.00747.x

M3 - Article

VL - 33

SP - 456

EP - 463

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 6

ER -